Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

D-0990-2019

March 01, 2019

Class III

Product summary

Firm
AVKARE Inc.
Event
Event 82296
Status
Terminated
Classification
Class III
Quantity
a) 2947 and b) 3379
Official record key
drug-enforcement:D-0990-2019

Official wording

Reason: Failed Dissolution Specifications

Code information: Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020

Distribution pattern: Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications